Rahaded, Patricia Valery and Herawati, Fauna (2024) Safety and Efficacy of R21/Matrix-M Vaccine Against and Eradicate Malaria Infection. Science Midwifery, 12 (2). pp. 918-925. ISSN 2086-7689; E-ISSN 2721-9453
PDF
1595-Article Text-8362-1-10-20240628.pdf - Published Version Download (525kB) |
Abstract
Malaria continues to be a substantial health concern, characterised by elevated rates of illness and death. The development of resistance to existing treatments poses unique obstacles to infection control initiatives. To combat the increasing incidence of malaria, it is imperative to create malaria vaccines such as RTS,S/AS01 and R21/Matrix-M. This study conducted a systematic literature revieew to evaluate the safety and efficacy of malaria vaccines that are currently being developed, with a specific focus on the R21/Matrix- M vaccine. Applying the PRISMA criteria, we identified five studies that specifically examined the efficacy and safety of the R21/Matrix- M vaccination. The findings indicated that the R21/Matrix-M vaccine exhibits favourable tolerability and demonstrates substantial efficacy in clinical studies. Nevertheless, the scarcity of research on the R21/Matrix-M vaccine thus far emphasises the necessity for additional investigation to substantiate its efficacy in malaria treatment.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Malaria, Vaksin R21/Matrix-M, Vaksin Malaria |
Subjects: | Q Science > QP Physiology R Medicine > R Medicine (General) |
Divisions: | Faculty of Pharmacy > Department of Pharmacy |
Depositing User: | PATRICIA VALERY RAHADED |
Date Deposited: | 23 Aug 2024 03:51 |
Last Modified: | 23 Aug 2024 03:51 |
URI: | http://repository.ubaya.ac.id/id/eprint/46977 |
Actions (login required)
View Item |